Creation of a clinical database for primary nervous system tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to create a comprehensive clinical database for patients diagnosed with primary central nervous system tumors (PCNST). It will collect data on the clinical, radiological, and biological characteristics of these tumors, as well as the effects of various oncological treatments and survival rates across different tumor subtypes. The database will facilitate the development of multicentric clinical studies and enhance understanding of rare histological subtypes, which currently have limited knowledge. By analyzing predictive and prognostic factors, the study seeks to improve treatment outcomes for patients with PCNST.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patient aged ≥ 18, no age limit;
* Diagnosis of Primary central nervous system tumors ;
* Patient treated at the Montpellier Cancer Institute, whatever the treatment received (systemic treatment, radiotherapy or exclusive supportive care);
* For the retrospective part of the study, patient first treated at the Montpellier Cancer Institute between January 1rst, 2004 and the beginning of the prospective part;
* Patient information for the retrospective (patient still alive at the beginning of the study) and prospective study.

Exclusion Criteria:

* Secondary lesions of the central nervous system;
* Patient not affiliated to a social protection scheme;
* Subject under tutelage, curatorship or safeguard of justice.

Where it's running

• Icm Val D'Aurelle
  Montpellier, Herault, France Recruiting

Study contacts

• Study coordinator: Aurore MOUSSION, MD
• Email: DRCI-icm105@icm.unicancer.fr
• Phone: 04 67 61 31 02

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Single‑session high‑dose lung radiotherapy and its effects on outcomes and quality of life

  This study tests whether a single high‑dose session of SBRT (30–34 Gy) works and how it affects quality of life for adults with small primary non‑small cell lung cancers or up to three lung metastases who are inoperable or refuse surgery.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier, ICM and 1 other locations · NCT07441941

• Prehabilitation with physiotherapy and mechanical stimulation before LD flap breast reconstruction

  This study tests whether prehabilitation with physiotherapy and mechanostimulation improves shoulder pain and mobility for women undergoing breast reconstruction with a latissimus dorsi flap.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Bordeaux, Aquitaine and 1 other locations · NCT07418060

• Music therapy with a tobacco‑addiction nurse to help people with cancer quit smoking

  This project will try whether personalized music therapy combined with support from a tobacco‑addiction nurse helps people with cancer who smoke reduce withdrawal symptoms and quit.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier, Herault · NCT07198971

• Preserving the superior left colic artery to improve blood flow to the descending colon before reconnecting the bowel after left-sided, rectal, or ovarian cancer surgery

  This trial will test in adults having left colon, rectal, or ovarian cancer surgery whether preserving the superior left colic artery and temporarily managing the inferior mesenteric artery improves blood flow to the descending colon and reduces healing problems after the bowel is reconnected.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier, Herault · NCT07098182

• Biobank for bronchial cancer patients to support research

  A biobank project will collect blood and tissue samples from adults with bronchial cancer to help researchers study biology and improve future treatments.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier, France · NCT07085429

• Analysis of circulating tumor markers in blood in lung cancer patients

  This study tests whether blood-based tumor markers can help understand and monitor lung cancer in adults to complement tissue tests.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier, France · NCT07060950

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.